ERBB2 and triple-negative breast carcinoma: Common molecular subtypes of breast cancer include luminal A (LA), luminal B (LB), human epidermal growth factor receptor 2 over-expression (HER2+) and triple negative breast cancer (TNBC), and different molecular subtypes show significant differences in biological behavior, clinical outcome and patient prognosis (Lüönd et al., 2021).